Filter
557
Filtered Results: 557
Text search:
metabolic
syndrome
Featured
Recommendations
84
New Publications
148
Language
Document type
No document type
320
Guidelines
111
Studies & Reports
67
Manuals
26
Training Material
12
Fact sheets
12
Strategic & Response Plan
9
Countries / Regions
India
58
Global
30
South Africa
16
Ethiopia
14
Kenya
14
Indonesia
12
Ghana
11
Uganda
10
Philippines
10
Rwanda
10
Zambia
8
Tanzania
8
Latin America and the Carribbean
8
Africa
7
Nepal
6
Bangladesh
6
Western and Central Europe
6
Sierra Leone
5
Nigeria
5
Cambodia
5
Namibia
5
Brazil
5
South–East Asia Region
5
Cameroon
4
South Sudan
4
Myanmar / Burma
4
Russia
4
North America
4
Liberia
3
Syria
3
Malawi
3
Eswatini/ Swaziland
3
USA
2
Germany
2
Thailand
2
Ukraine
2
Botswana
2
Eastern Europe and Central Asia
2
Asia
2
Venezuela
2
Eastern Europe
2
Zimbabwe
1
Somalia
1
China
1
Mozambique
1
Sudan
1
Peru
1
North Macedonia
1
Colombia
1
Ecuador
1
Lesotho
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Paraguay
1
Fiji
1
Jamaica
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
229
Clinical Guidelines
106
Public Health
57
Women & Child Health
40
Capacity Building
11
Key Resources
6
Pharmacy & Technologies
3
Toolboxes
Mental Health
56
NCDs
47
COVID-19
34
HIV
25
TB
17
Caregiver
17
Pharmacy
14
Ebola
10
AMR
10
Planetary Health
10
Disability
9
Rapid Response
9
Global Health Education
8
Conflict
7
NTDs
7
Specific Hazards
6
Zika
5
Refugee
4
Polio
3
Cholera
1
This Review summarizes many of the persistent biological alterations associated with childhood maltreatment including changes in neuroendocrine and neurotransmitter systems and pro-inflammatory cytokines in addition to specific alterations in brain areas associated with mood regulation. Finally, I d...
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
Paediatrics
Chapter I.2
Developmental disorders
Chapter C.5
Session outline
•Introduction to psychoses.
•Assessment of psychoses.
•Management of psychoses.
•Follow-up.
•Review.
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Accessed Febr.6, 2020
Accessed Febr. 6 ,2020
April 2020
This Guidance Note offers a list of recommendations based on a combination of WHO guidelines, good practice and expert advice based on the latest scientific research. The situation with COVID-19 is evolving rapidly and the guidance will continue to be updated if and when new evidence o...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Special issue: WHO South-East Asia Journal of Public Health -Vol. 5, Issue 1, April 2016.This special This issue contains a rich collection of articles, demonstrating the encouraging scientific momentum to address the growing burden of diabetes in the region
